Penicillin G (parenteral)
Benzylpenicillin sodium
Brand names: Crystapen
Adult dose
Dose: 1.2–2.4g IV q4–6h (severe infection); meningococcal sepsis pre-hospital: 1.2g IM/IV
Route: IV / IM
Frequency: q4–6h
Clinical pearls
- NICE NG52 / UKHSA: meningococcal sepsis pre-hospital
- BNF/JFC: streptococcal infections, syphilis (alternative to benzathine)
- BSAC / UKHSA AMR — narrow-spectrum
Contraindications
- Penicillin hypersensitivity
Side effects
- Hypersensitivity / anaphylaxis
- Diarrhoea / C. difficile
- Jarisch-Herxheimer (syphilis)
- Encephalopathy (high-dose, renal impairment)
- Haemolytic anaemia (rare)
Interactions
- Probenecid
- Methotrexate
- Anticoagulants (rare)
Monitoring
- Renal function
- C. diff
- Resolution
Reference: BNF; NICE NG52; UKHSA; BSAC; https://bnf.nice.org.uk/drugs/benzylpenicillin-sodium/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023